GRGeorges Raad

Georges Raad

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Georges Raad has a total of 111 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Response to the Letter by Xin & Zeng on sex-specific psychological resilience and blastocyst quality in ICSI cycles

    by Georges Raad, Youmna Mourad, Gaelle El Asmar, Zalihe Yarkiner, Fatima Ibrahim, Jad El Ahdab, Münevver Serdaroğulları, Ghina Ghazeeri, Anwar Nassar, Chadi Fakih

  • Open Access

    Cumulus cell DNA fragmentation in relation to oocyte yield and blastocyst quality

    by Georges Raad, Youmna Mourad, Gaelle El Asmar, Zalihe Yarkiner, Fadi Fakih, Ghina Ghazeeri, Chadi Fakih

    The objective of this study was to evaluate whether cumulus cell (CC) DNA fragmentation is associated with oocyte yield and the probability of obtaining at least one good-quality day-5 blastocyst in intracytoplasmic sperm injection (ICSI) cycles. A prospective cohort study was conducted in 112 infertile couples undergoing ICSI between March 2024 and November 2025. CC DNA fragmentation was assessed using a chromatin dispersion assay and expressed as the percentage of fragmented cells. The primary outcome was the probability of obtaining at least one good-quality day-5 blastocyst (≥3BB). Higher CC DNA fragmentation was negatively correlated with the numbers of collected cumulus–oocyte complexes (COCs) and metaphase II oocytes (all P < 0.05). In adjusted negative binomial regression models, higher DNA fragmentation remained independently associated with fewer collected COCs (incidence rate ratio (IRR): 0.97, 95% confidence interval (CI): 0.96–0.98; P < 0.001) and fewer metaphase II oocytes (IRR: 0.97, 95% CI: 0.96–0.99; P = 0.001). However, no evidence of an association between CC DNA fragmentation and the probability of obtaining at least one good-quality blastocyst was observed after adjustment for female age, BMI and total motile sperm count. These findings suggest that higher CC DNA fragmentation is associated with reduced oocyte yield, whereas its association with blastocyst quality remains uncertain. Lay summary: Eggs develop inside the ovary surrounded by supporting cells called cumulus cells. These cells help nourish the egg and may provide information about its quality. In this study, we investigated whether damage to the DNA of cumulus cells was associated with the outcomes of fertility treatment. We studied 112 couples undergoing intracytoplasmic sperm injection (ICSI) and measured the amount of DNA damage in cumulus cells collected during treatment. We found that higher levels of DNA damage were associated with fewer eggs being obtained. However, DNA damage in cumulus cells was not associated with the chance of obtaining a high-quality blastocyst. These findings suggest that cumulus cell DNA damage may not reflect embryo quality but could provide insight into egg development.

  • Open Access

    Sex-specific associations between psychological resilience and blastocyst quality

    by Georges Raad, Youmna Mourad, Gaelle El Asmar, Zalihe Yarkiner, Fatima Ibrahim, Jad El Ahdab, Münevver Serdaroğulları, Ghina Ghazeeri, Anwar Nassar, Chadi Fakih

    Psychological resilience is an adaptive capacity that enables individuals to maintain or regain equilibrium following stress. Infertility treatment represents a significant psychological stressor for many couples. Although higher resilience has been associated with better psychological well-being in patients undergoing medically assisted reproduction, its relationship with embryological outcomes remains unknown. This study aimed to determine whether psychological resilience in couples undergoing infertility treatment is associated with blastocyst quality. In this prospective observational study, a total of 126 infertile couples who underwent intracytoplasmic sperm injection using fresh autologous gametes were included. Psychological resilience in both partners was assessed using the 10-item Connor–Davidson Resilience Scale. The numbers of mature oocytes retrieved, semen parameters, and sperm histone retention were evaluated. The primary outcome was the day 5 good-quality blastocyst development rate. Higher psychological resilience in men, but not in women, was independently associated with a higher good-quality blastocyst development rate (B = 0.06, 95% CI: 0.01–0.11, P = 0.02) and remained significant in sensitivity analyses. Male resilience was also positively correlated with sperm morphology (ρ = 0.28, P = 0.001) and inversely correlated with sperm histone retention (ρ = −0.26, P = 0.02). Psychological resilience in men, but not in women, was associated with sperm characteristics and blastocyst quality in couples undergoing infertility treatment. These findings suggest that psychological factors may be reflected in biological parameters relevant to reproduction. Further studies are needed to investigate the underlying mechanisms and reproductive outcomes beyond embryo development. Lay summary: Psychological resilience is the ability to adapt to and recover from stressful situations. Infertility treatment can be emotionally challenging for couples, but it is not known whether resilience is related to laboratory outcomes during treatment. In this study, we assessed psychological resilience in 126 couples undergoing intracytoplasmic sperm injection, a fertility treatment in which one sperm is injected into each mature egg. We found that higher resilience in men was associated with better sperm characteristics and a higher rate of good-quality embryos reaching the blastocyst stage on day 5. This association was not observed in women. These findings suggest that psychological factors in men may be linked to biological features relevant to reproduction. However, this was an observational study and cannot establish cause and effect. Larger studies are needed to confirm these findings and to understand the biological mechanisms involved.

  • The drawbacks of paternal obesity on sperm biology, preimplantation embryo morphokinetics, and its transgenerational impacts

    by Georges Raad

    L’effet de l’obésité paternelle acquise sur la biologie des spermatozoïdes, la cinétique de division embryonnaire, et sur l’hérédité transgénérationelle: L'obésité est une condition médicale résultant d'une accumulation excessive de dépôts adipeux. Le remodelage pathologique du tissu adipeux chez les sujets obèses pourrait conduire à l'élaboration de plusieurs problèmes de santé. Malheureusement, la prévalence de l'obésité augmente dans le monde entier et en particulier chez les jeunes hommes en âge de procréation. En outre, plusieurs études ont suggéré que les informations de l'environnement paternel comme l'obésité acquise restent dans l’épigénome du spermatozoïde et peuvent moduler le phénotype de la descendance. Pour toutes ces raisons, une compréhension plus approfondie des effets de l’obésité sur la composition moléculaire des spermatozoïdes est nécessaire. Le premier objectif de cette thèse était d'évaluer l'effet de l'obésité sur la composition moléculaire et sur la physiologie des spermatozoïdes mobiles. Les échantillons de sperme ont été obtenus à partir de 96 hommes s’adressant au centre de fertilité ‘A-clinic’, Liban. Les patients ont été classés en trois groupes : poids normal, le surpoids, et obèses. Nos résultats ont montré qu’il y a une rétention des histones plus élevée, et un ADN spermatique hypométhylé et hypohydroxymethylé, dans les spermatozoïdes mobiles des hommes obèses par rapport à ceux des hommes non-obeses. Par conséquent, les embryons issus de spermatozoïdes mobiles d'un homme obèse avaient une cinétique de division embryonnaire altérer par rapport à ceux provenant des spermatozoïdes d’un homme de poids normal

  • Open Access

    Efficacy of 10 days high-dose and double-dose rabeprazole-based concomitant therapy for Helicobacter pylori eradication among Lebanese population: a pilot randomized controlled trial

    by Marc Elias, Charbel Yazbeck, Anthony Zaarour, Vanessa Sleiman, Nancy Sakr, Georges Raad, Bassem Akiki

    The aim of this study is to optimize Helicobacter pylori (H. pylori) eradication by increasing the proton pump inhibitor (PPI) dose and reducing the treatment duration of antibiotics without compromising the treatment’s safety and efficacy. This pilot randomized controlled trial included 120 patients from Notre Dame des Secours University Hospital in Byblos, Lebanon, between February 2023 and December 2023. Participants were Lebanese adults with H. pylori infection confirmed by upper gastrointestinal endoscopy. Exclusion criteria included pregnancy or nursing, malignancy or gastric mucosa-associated lymphoid tissue lymphoma, allergy or contraindications to study drugs, active upper gastrointestinal bleeding, prior gastric surgeries, recent use of PPIs or antibiotics, celiac disease, previous H. pylori treatment, or refusal to consent. Eligible patients (n = 113) were randomly assigned into three groups: Group A (n = 38) received a standard-dose of rabeprazole 20 mg twice daily for 14 days with concomitant therapy, Group B (n = 37) received a double-dose of rabeprazole (20 mg twice per day) for 10 days with concomitant therapy, and Group C (n = 38) received a high-dose of rabeprazole (20 mg three times per day) for 10 days with concomitant therapy. Eradication was assessed by urea breath test six weeks after treatment completion. Out of 120 participants, 101 patients were considered for analysis, while 19 patients were excluded (15.8%). Of these exclusions, 7 patients were excluded before randomization due to drug allergy and opted for alternative treatment (5.8%), while 12 were excluded after randomization due to loss to follow-up (12%). The results indicated that the high-dose PPI group C had the highest percentage of negative breath tests (100%), followed by the standard treatment group A with 94.7%, and then group B with 83.3%. However, given the pilot nature and sample size of this study, these results, particularly the 100% rate in Group C, should be interpreted as preliminary and require confirmation in a larger trial. The use of high-dose PPI with 10 days of concomitant therapy (Group C) demonstrated the highest eradication rate among the study groups. This promising finding suggests a potential benefit of the high-dose PPI regimen with 10-day concomitant therapy but must be interpreted with caution; it warrants further investigation in a larger and adequately powered randomized controlled trial to confirm its efficacy and generalizability, given the pilot nature of this study. Lebanon clinical trial registry; LBCTR2025075755; 14/08/2025.


  • Sperm vacuolization and mitochondrial activity in raw versus prepared semen: effect on embryological outcomes

    by Georges Raad, Jana El Sayegh, Nisrine El Roz, Marwa Bazzi, Zalihe Yarkiner, Munevver Serdarogullari, Georgios Liperis, Omar Ammar, Fadi Fakih, Youmna Mourad, et al.

  • Open Access

    Iron biomarkers in men with infertility are associated with sperm DNA hydroxymethylation and cumulative live birth rates: a prospective study

    by Georges Raad, Fatima Husseiny, Zalihe Yarkiner, Valerie Grandjean, Marwa Bazzi, Marilyne Rizk, Fadi Fakih, Youmna Mourad, Chadi Fakih

    Pregnancy rates after intracytoplasmic sperm injection (ICSI) could be influenced by sperm quality. Maintaining iron homeostasis is crucial for both sperm quality and the activity of ten-eleven translocation (TET) enzymes. TETs play a role in DNA chemical modifications. However, the impact of iron biomarkers on the sperm DNA chemical modifications and pregnancy outcomes has not been explored. This prospective study aimed to assess whether iron biomarkers in men from infertile couples were associated with global DNA hydroxymethylation (5-hmC) in spermatozoa and cumulative live birth rates (CLBR). Semen and blood samples were collected from 60 infertile men undergoing ICSI cycles with their female partners, alongside medical histories and CLBR outcomes. Serum and seminal fluid levels of iron, transferrin, and total iron binding capacity (TIBC) were measured, and sperm global DNA 5-hmC was quantified using ELISA-based colorimetric assays. 5-hmC levels in spermatozoa were positively correlated with serum iron (R = 0.29; p = 0.04), serum TIBC (R = 0.29; p = 0.04), and seminal fluid iron (R = 0.30; p = 0.04). Univariate analysis showed that a 1 µg/dl increase in seminal fluid or serum iron was associated with a 0.001% rise in 5-hmC (p < 0.05), and each unit increase in serum TIBC led to a 0.001% rise in 5-hmC (p = 0.03). Multivariate regression confirmed that higher serum TIBC levels were significantly associated with increased 5-hmC (%) (p = 0.02). Additionally, multivariate analysis revealed that a 1 µg/dl increase in seminal fluid iron was associated with a 1.016% rise in CLBR (p = 0.0009), while a 1 mg/dl increase in seminal fluid transferrin was associated with a 3.754% decrease in CLBR (p = 0.04). Serum TIBC is positively associated with sperm 5-hmC, while seminal iron shows a positive and transferrin a negative association with CLBR.


  • Open Access

    Preconceptional paternal obesity may increase the risk of congenital urogenital anomalies in offspring: A case–control study

    by Mariella El Achkar, Ornina Atieh, Carole Ghadban, Toufic Awad, Elie Ghadban, Valérie Grandjean, Zalihe Yarkiner, Georges Raad, Marie‐Claude Fadous Khalife

    Background: Congenital urogenital anomalies affect 4–60 per 10,000 births. Maternal obesity, along with other risk factors, is well documented as a contributing factor. However, the impact of paternal obesity on risk is unclear. Obesity is prevalent among men of reproductive age, highlighting the need for further research into the potential association between paternal obesity and offspring congenital urogenital anomalies.Objectives: This study aims to determine the association between paternal obesity and the risk of congenital urogenital malformations in offspring.Methods: Case–control study conducted on 179 newborns (91 cases, 88 controls) selected from the Notre Dame des Secours—university hospital database. Cases were identified as newborns presenting at least one congenital urogenital abnormality, defined as developmental anomalies that can result in a variety of malformations affecting the kidneys, ureters, bladder, and urethra. Controls were identified as newborns without any congenital abnormalities. The exclusion criteria were maternal obesity, infections during pregnancy, chronic diseases, prematurity, growth retardation, assisted reproductive technologies for conception, substance abuse, down syndrome, and other malformations. Data were collected through phone interviews, medical records, and questionnaires. In this study, the exposure was the preconceptional paternal body mass index (BMI), which was calculated based on self‐reported height and weight. According to guidelines from the US Centers for Disease Control and Prevention (CDC), individuals are considered to be in the healthy weight range if their BMI (kg/m2) is between 18.5 and < 25. They are classified as overweight if their BMI is ≥ 25, obese class I if their BMI is between 30 and < 35, obese class II if their BMI is between 35 and < 40, and obese class III if their BMI is 40 or higher. Logistic regression analysis was employed to quantify the association between paternal obesity and urogenital conditions in offspring.Results: Significant differences in median (minimum–maximum) paternal BMI values were noted between the cases and controls at the time of conception (cases: 27.7 (43–20.1), controls: 24.8 (40.7–19.6); p < 0.0001). Logistic regression analysis confirmed that at the time of conception, compared to normal‐weight fathers, overweight fathers displayed a heightened risk of offspring congenital malformations, with an odds ratio (OR) of 4.44 (95% CI = 2.1–9.1). Similarly, fathers categorized as obese Class I at conception had approximately eight times higher odds (OR = 8.62, 95% CI = 2.91–25.52) of having offspring with urogenital conditions compared to normal‐weight fathers. Additionally, fathers classified as obese Class II at conception exhibited 5.75 times higher odds (OR = 5.75, 95% CI = 0.96–34.44) of having offspring with urogenital conditions in comparison to normal‐weight fathers.Discussion and conclusion: We found that the risk of urogenital malformations increased with paternal BMI during the preconceptional period. The findings suggest the importance of addressing paternal obesity in efforts to reduce the risk of urogenital congenital malformations in offspring.


  • Open Access

    Paternal peri‐conceptional physical activity and the risk of congenital heart disease in offspring: A case–control study

    by Ornina Atieh, Nohad Maria J. Azzi, Georges J. Lteif, Ninar A. Atieh, Nadim Y. Germanos, Valérie Grandjean, Zalihe Yarkiner, Zakhia Saliba, Marie‐Claude Fadous Khalife, Georges Raad

    Background: Genetic and environmental factors have been shown to contribute to the development of congenital heart disease (CHD). To date, the focus of scientific articles has primarily centered on genetics and maternal environmental factors, with comparatively less attention given to paternal risk factors.Objectives: This study aims to investigate the potential association between paternal pre‐conceptional physical activity levels (PA), along with paternal peri‐conceptional smoking and alcohol consumption, and the risk of CHD in offspring.Materials and methods: An observational case–control study was conducted in Lebanon, with 279 participants, aiming to investigate potential risk factors for CHD. We included children with confirmed CHD, born between 2012 and 2022. Controls born in the same timeframe were selected randomly from the general population using online questionnaire forms. Mean age of children included was 6 years old (0–10). The pre‐conceptional PA was assessed using the Global Physical Activity Questionnaire validated in Arabic. In addition, paternal smoking, alcohol consumption, and maternal risk factors were collected.Results: The study included 128 CHD cases (45.9%) and their parents, as well as 151 healthy infants (54.1%) and their parents. There were no statistically significant variations in the alcohol consumption noted between the fathers in the case and control groups (p = 0.18). The paternal involvement in recreational‐related PA during the peri‐conception period was associated with a reduced risk of the CHD development in offspring by 46.9% (OR = 0.531, 95% CI: 0.301–0.936, p = 0.029). Additionally, increasing paternal total sitting time by 1 h above the average, which was approximately 260 min (4 h), increased the risk of CHD in offspring by 0.4% (p = 0.001). Moreover, paternal smoking exhibited an apparent association with a 56% increased risk of offspring developing CHD, notwithstanding that the confidence intervals included the null (OR = 1.56, 95% CI: 0.86–2.8, p = 0.136).Discussion and conclusion: This observational study is the first to report a potential association between paternal PA, and CHD in offspring. This study aligns with previous reports, advocating for the paternal engagement in PA and the adoption of healthy lifestyle habits, especially during the critical stages of conception. Such practices are strongly recommended to enhance fertility and promote optimal health for offspring. However, due to the subjectivity in reporting PA and lack of molecular proof, additional prospective and molecular studies are required to validate these findings.


  • Open Access

    Low E-visibility of embryologists on fertility clinic websites: a web-based cross-sectional study

    by Fadi Choucair, Okan Atilan, Abdulla Almohammadi, Nagham Younis, Alia Al Hourani, Carol Lynn Curchoe, Georges Raad

    Purpose This study assessed the visibility of embryologists on fertility clinic websites among Society for Assisted Reproductive Technology (SART) and the Human Fertilisation and Embryology Authority (HFEA) member clinics. Methods During a 1-month interval (March 2022), all Society for Assisted Reproductive Technology (SART) and the Human Fertilisation and Embryology Authority (HFEA) member fertility clinic websites were evaluated. The professional representation of the primary care team was examined including specialties, the presence of headshots, and biographies. Results A total of 446 fertility clinic websites were scanned in the search. The embryology team has the least common professional identification by their names (53.58%) compared to gynecology clinicians (96.21%, p < 0.001) and nurses (55.58%, p < 0.001). This trend also applies to other types of professional identifiers, such as headshots and biographies. Professional headshots of embryologists (50.34%) were less prominent than those of gynecology clinicians (93.51%, p < 0.001). A similar trend was observed in the biographies of the embryology team (47.20%) compared to gynecology clinicians (95.08%, p < 0.001). Conclusion The present study revealed that embryologists have low professional visibility on fertility clinic websites. Fertility clinics may prioritize enhancing the online visibility of their embryology laboratory team. This approach could potentially enhance the recognition of their team, foster transparency, and provide accessible information about the skills and expertise of healthcare professionals involved in the treatment process.